CHRIS SWONGER

H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.

H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; issues related to tort reform.

H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; issues related to tort reform.

H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.

H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; issues related to the repeal of the medical device excise tax. Tax reform; international tax issues; manufacturing and taxes.

H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; issues related to the repeal of the medical device excise tax. Tax reform; international tax issues; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; generally.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. S.3040/House Committee Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; P.L.114-254, Further Continuing and Security Assistance Appropriations Act, 2017; generally.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. S.3040/House Committee Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; P.L.114-254, Further Continuing and Security Assistance Appropriations Act, 2017; generally.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; generally.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; P.L.114-255, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; P.L.114-255, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. S.3040/House Committee Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; P.L.114-254, Further Continuing and Security Assistance Appropriations Act, 2017; generally.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; generally.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; generally.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues. P.L.114-223, Making continuing appropriations for fiscal year 2017, and for other purposes; P.L.114-254, Further Continuing and Security Assistance Appropriations Act, 2017; generally.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. S.3040/House Committee Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. S.3040/House Committee Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018, Patient Access to Disposable Medical Technology Act of 2015; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018, Patient Access to Disposable Medical Technology Act of 2015; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

Funding for aviation security and homeland security technologies. S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2014 Department of Defense Appropriations Act (H.R.2397/S.1429); chemical and biological counter measures. FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. P.L.113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

S.1, Keystone XL Pipeline Approval Act and H.R.3, Keystone XL Pipeline Act; issues related to approval of Keystone Pipeline. Issues related to energy infrastructure.

S.1, Keystone XL Pipeline Approval Act and H.R.3, Keystone XL Pipeline Act; issues related to approval of Keystone Pipeline. Issues related to energy infrastructure.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. P.L.113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2014 Department of Defense Appropriations Act (H.R.2397/S.1429); chemical and biological counter measures. FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. P.L.113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018, Patient Access to Disposable Medical Technology Act of 2015; issues related to patient infusion therapy.

S.1, Keystone XL Pipeline Approval Act and H.R.3, Keystone XL Pipeline Act; issues related to approval of Keystone Pipeline. Issues related to energy infrastructure.

S.1, Keystone XL Pipeline Approval Act and H.R.3, Keystone XL Pipeline Act; issues related to approval of Keystone Pipeline. Issues related to energy infrastructure.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018, Patient Access to Disposable Medical Technology Act of 2015; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; issues related to patient infusion therapy.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2014 Department of Defense Appropriations Act (H.R.2397/S.1429); chemical and biological counter measures. FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. P.L.113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. P.L.113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2014 Department of Defense Appropriations Act (H.R.2397/S.1429); chemical and biological counter measures. FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2014 Department of Defense Appropriations Act (H.R.2397/S.1429); chemical and biological counter measures. FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. P.L.113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.

Funding for aviation security and homeland security technologies. H.R.3128/S.1619, Department of Homeland Security Appropriations Act, 2016; Transportation Security Administration (TSA) funding issues. H.R.2685/S.1558, Department of Defense Appropriations Act, 2016; chemical and biological counter measures. S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; medical device funding and policy. Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015; Division C-Department of Defense National Guard funding. Monitor the following: FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.